Evidence map›Paper›PMID 32062698›Full record

ArticleEuropean radiology2020

Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?

Taiyo L Harada, Takayoshi Uematsu, Kazuaki Nakashima, Takashi Sugino, Seiichirou Nishimura, Kaoru Takahashi, Tomomi Hayashi, Yukiko Tadokoro, Junichiro Watanabe, Shogo Nakamoto and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Taiyo L HaradaDivision of Breast Imaging and Breast Interventional Radiology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Shizuoka Prefecture, 411-8777, Japan. l.harada@scchr.jp.ORCID http://orcid.org/0000-0002-3205-9440
Takayoshi UematsuDivision of Breast Imaging and Breast Interventional Radiology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Shizuoka Prefecture, 411-8777, Japan.
Kazuaki NakashimaDivision of Breast Imaging and Breast Interventional Radiology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Shizuoka Prefecture, 411-8777, Japan.
Takashi SuginoDivision of Pathology, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Seiichirou NishimuraDivision of Breast Surgery, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Kaoru TakahashiDivision of Breast Surgery, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Tomomi HayashiDivision of Breast Surgery, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Yukiko TadokoroDivision of Breast Surgery, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Junichiro WatanabeDivision of Breast Oncology, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Shogo NakamotoDivision of Breast Oncology, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Takahiro ItoDivision of Diagnostic Radiology, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Shizuoka Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGiven that a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) is an important prognostic factor, evaluating pretreatment imaging findings is important. Outcomes for triple negative breast cancer (TNBC) vary with the histological classification, indicating that this classification is clinically significant. In this study, we focus on the most common histological subtype of TNBC, invasive carcinoma of no special type (NST), to evaluate whether intramammary edema (intra-E) and intratumoral necrosis (intra-N) on T2-weighted magnetic resonance imaging (T2WI) is a useful predictor of pCR.

methodWe retrospectively included patients with biopsy-diagnosed TNBC-NST who received NAC between January 2014 and December 2017. Intra-E and intra-N were evaluated on T2WI before NAC. We grouped intra-E into no edema, peritumoral edema, prepectoral edema, and subcutaneous edema, and we defined intra-N as water-like signal intensity without enhancement on T2WI. We also evaluated tumor size, Ki-67 expression, and histological/nuclear grade, as well as their correlation with intra-E and intra-N.

resultsFifty-seven patients with TNBC-NST were enrolled. There was no correlation with the rate of pCR and the presence of either intra-E or intra-N before NAC. Only intra-E and tumor size showed a positive correlation.

conclusionsIn patients with TNBC-NST, intra-E and intra-N did not correlate with pCR, but intra-E did positively correlate with tumor size. NST may exhibit a greater response to NAC, regardless of whether intra-E or intra-N is present or not on the pretreatment MRI. KEY POINTS: • Pathological complete response in TNBC-NST had no correlation with intramammary edema or intratumoral necrosis. • NAC may be justified in TNBC-NST even in the presence of edema or necrosis. • The extension of edema correlated with tumor size of TNBC-NST.

Indexed as

Neoadjuvant TherapyAdultAgedAntineoplastic AgentsBreastBreast NeoplasmsCarcinoma, Ductal, BreastEdemaFemaleHumansMagnetic Resonance ImagingMiddle AgedNecrosisPrognosisRadiographyRetrospective StudiesAntineoplastic AgentsChemotherapyEdemaMagnetic resonance imagingNecrosisTriple negative breast cancer

Identifiers

PMID32062698
OpenAlexW3005756010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.